Full Text View
Tabular View
Study Results
Related Studies
Effect on Weight Loss of Exenatide Versus Placebo
This study has been completed.
Study NCT00375492   Information provided by Amylin Pharmaceuticals, Inc.

First Received on September 11, 2006.   Last Updated on July 1, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Signs and Symptoms
Interventions listed in this trial
exenatide
placebo
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Amylin Pharmaceuticals, Inc.
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services